Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-16 Sale | 2026-06-17 4:07 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 145 | $18.33 | $2,658 | 154,208 (Direct) | View |
| 2026-05-13 Sale | 2026-05-14 4:05 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 228 | $18.36 | $4,186 | 154,353 (Direct) | View |
| 2026-03-05 Sale | 2026-03-06 4:10 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 148 | $14.9 | $2,205 | 154,581 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 4:08 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 144 | $20.72 | $2,984 | 94,729 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 4:06 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 1,038 | $13.29 | $13,794 | 94,873 (Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:03 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 146 | $13.35 | $1,949 | 95,911 (Direct) | View |
| 2025-03-13 Sale | 2025-03-13 4:13 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 143 | $12.12 | $1,733 | 96,057 (Direct) | View |
| 2023-03-03 Sale | 2023-03-07 2:04 pm | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer | 1,482 | $22.82 | $33,819 | 148,518 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-12 Option Award | 2026-02-17 5:09 pm | N/A 2036-02-11 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 150,000 | $0 | 244,729 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:21 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 51,255 | $0 | 51,255 (Direct) | View |
| 2024-12-04 Option Award | 2024-12-06 4:05 pm | N/A 2034-12-03 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 98,100 | $0 | 156,500 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-03 6:16 pm | N/A 2034-09-02 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 243,700 | $0 | 243,700 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 8:27 pm | N/A 2033-02-21 | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna EVP & Chief Operating Officer | 130,000 | $0 | 220,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-08 11:35 am | N/A 2032-03-01 | Vir Biotechnology Inc. | VIR | Friedl-Naderer Johanna Chief Business Officer, Global | 135,000 | $0 | 135,000 (Direct) | View |